APA (7th ed.) Citation

Tao, L., Zhou, Y., Pan, X., Luo, Y., Qiu, J., Zhou, X., . . . Zhao, Y. (2023). Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51. Nature Communications, 14(1), 1. https://doi.org/10.1038/s41467-023-42850-x

Chicago Style (17th ed.) Citation

Tao, Lei, et al. "Repression of LSD1 Potentiates Homologous Recombination-proficient Ovarian Cancer to PARP Inhibitors Through Down-regulation of BRCA1/2 and RAD51." Nature Communications 14, no. 1 (2023): 1. https://doi.org/10.1038/s41467-023-42850-x.

MLA (9th ed.) Citation

Tao, Lei, et al. "Repression of LSD1 Potentiates Homologous Recombination-proficient Ovarian Cancer to PARP Inhibitors Through Down-regulation of BRCA1/2 and RAD51." Nature Communications, vol. 14, no. 1, 2023, p. 1, https://doi.org/10.1038/s41467-023-42850-x.